Tech and Weed: This 2-Stock Combo Packs a Punch

Tech stock Kinaxis Inc. (TSX:KXS) pairs nicely with a leading weed stock to make a powerful duo for growth investors.

| More on:

Tech and weed are starting to look like less strange bedfellows than they did this time last year, with solid returns in both industries and a raft of solid stats in some outperforming stocks. Let’s take a look at two of the best-matched tickers in these sectors and see why they get the thumbs up.

The sky’s the limit for this cloud-based tech ticker

Offering a subscription service for supply chain management solutions, with software based in the cloud for added usability and security, Kinaxis (TSX:KXS) is one of the leading tech stocks on the TSX index. Nevertheless, it saw its share price drop precipitously after an earnings update back in November but started to see a recovery as quickly as the following month. Since then, Kinaxis has seen its share price rise and fall, leading to the current value opportunity.

Indeed, down by a significant 4.29% in the last five days, tech fans waiting for a pullback may be in luck, with its current overvaluation still something of a concern. Indeed, from a high P/E ratio topping 100 times earnings and trading at almost eight times its book value, Kinaxis is anything but cheap. Still, every stock exchange has its outlandish market ratios, and not every wayward P/E signifies an off-limits purchase.

Kinaxis is expected to make efficient use of shareholders’ funds in the future, with a projected return on equity of 22.2% over the next three years. A strong play if you’re also looking to add exposure to the growing field of artificial intelligence, Kinaxis has managed to deliver 46.7% year-on-year earnings growth over the past five years. Despite high market ratios, there’s a potent mix of future performance indicators and healthy balance sheet stats.

Add a top pot stock to make your portfolio pop

Up 7.34% over the past five days and with year-on-year returns of 122.1%, HEXO (TSX:HEXO) is an outperforming stock worthy of a growth investor’s mid-term portfolio. Though its P/B ratio of 4.6 times the book value is higher than the standard TSX index stock, HEXO is still relatively better valued than some other high-profile pot stocks.

What’s of particular note here is that HEXO is up while the cannabis sector on the whole is down; this indicates a good entrance weed stock for the newcomer, with the kind of upward momentum that should bring quick rewards. Indeed, having almost doubled since the start of the year, it’s recently been given a “buy” signal by no less an institution than the Bank of America.

The bottom line

The cloud-based tech stock pairs nicely with what is widely held to be one of the leading weed stocks to make a powerful pairing for growth investors. A strong balance sheet and sturdy 25.7% expected annual growth in earnings make Kinaxis a sensible addition to a tech stock portfolio, even though it’s not exactly a bargain. Meanwhile, adding a weed stock like HEXO, with its 89.5% projected growth in earnings over the next one to three years, would make for a powerful tag team.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned. Kinaxis is a recommendation of Stock Advisor Canada.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »